Compare LRMR & AXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRMR | AXIN |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.0M | 274.3M |
| IPO Year | 2014 | N/A |
| Metric | LRMR | AXIN |
|---|---|---|
| Price | $4.72 | $10.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.29 | N/A |
| AVG Volume (30 Days) | ★ 6.5M | 76.6K |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $9.93 |
| 52 Week High | $6.42 | $10.15 |
| Indicator | LRMR | AXIN |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 53.25 |
| Support Level | $3.18 | $10.11 |
| Resistance Level | $5.37 | $10.15 |
| Average True Range (ATR) | 0.61 | 0.01 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 57.49 | 50.00 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Axiom Intelligence Acquisition Corp 1 is a blank check company.